Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC

Amplification of the mesenchymal epithelial transition (MET) gene is a mechanism of acquired resistance to epidermal growth factor receptor (EGFR)-tyrosine-kinase-inhibitors (TKIs) in over 20% of patients with advanced EGFR-mutated (EGFRm+) non-small lung cancer (NSCLC). However, it may also occur d...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbanska, Edyta M., Grauslund, Morten, Koffeldt, Peter R., Truelsen, Sarah L. B., Löfgren, Johan O., Costa, Junia C., Melchior, Linea C., Sørensen, Jens B., Santoni-Rugiu, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487649/
https://www.ncbi.nlm.nih.gov/pubmed/37685884
http://dx.doi.org/10.3390/ijms241713077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487649/
https://www.ncbi.nlm.nih.gov/pubmed/37685884
http://dx.doi.org/10.3390/ijms241713077

Ejemplares similares